New Insights to Enhance Blood Cancer Diagnosis and Treatment
The study’s impact is multifaceted, potentially influencing the development of non-invasive diagnostic tests and novel medicines.
Read MorePosted by Andy Lundin | Sep 13, 2023 | Unknown Origin & Other Cancer Types |
The study’s impact is multifaceted, potentially influencing the development of non-invasive diagnostic tests and novel medicines.
Read MorePosted by Andy Lundin | Aug 10, 2023 | Microscopy |
Scientists developed an AI system that recognizes and characterizes white and red blood cells in microscopic images of blood samples.
Read MorePosted by Andy Lundin | Aug 8, 2023 | Unknown Origin & Other Cancer Types |
Blood disorders known as MDS are difficult to diagnose putting patients at increased risk for treatment mistakes from misdiagnosis.
Read MorePosted by Melanie Hamilton-Basich | Jun 26, 2023 | Unknown Origin & Other Cancer Types |
By testing a range of therapies in organoids grown from the patient’s own tumor sample, SEngine’s PARIS Test identified off-label therapy that proved highly successful for one ovarian cancer patient.
Read MorePosted by Melanie Hamilton-Basich | Jun 14, 2023 | Molecular Diagnostics, Unknown Origin & Other Cancer Types |
Precipio’s HemeScreen Cytopenia panel enabled a patient’s diagnosis without the need for a painful, invasive bone marrow biopsy.
Read More